The idea that Affordable Care Act marketplaces are riddled with fraud has become a major talking point among Republicans, as lawmakers in Congress argue about whether to extend the enhanced tax credits that are helping offset the cost of health care marketplace coverage for low- and middle-income people. Those ACA subsidies expire at the end…
Listen: Health care has been at the heart of the federal government’s shutdown. KFF Health News chief Washington correspondent Julie Rovner appeared on WAMU’s Oct. 22 “Health Hub” to explain the health care compromises some lawmakers want before they will agree to reopen the government. Affordable Care Act tax credits are at the heart of…
By KIM BELLARD When I saw a headline about “DNA flowers,” I was nonplused. I mean: aren’t all flowers made out of DNA, like every living thing on our planet? Well, it turns out that the DNA flowers are actually soft robots – make that nanobots – so my interest was definitely piqued. The DNA…
As always, this year’s HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s most notable announcements. The post 7 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.
How do you write a good grant proposal? How do you write a good proposal for any type of project? Jim Olds– the former head of NSF’s Biological Sciences Directorate –provides some fantastic advice in his post “What Grant Reviewers Actually Look For (and What They Ignore)“. He distills what grant reviewers want into 5…
During a Monday session at the HLTH Conference in Las Vegas, Centene CEO Sarah London shared her thoughts on ICHRA, calling it the “future of individual health insurance.” The post Centene CEO: ICHRA Is the Future of Individual Health Insurance appeared first on MedCity News.
Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group’s Optum subsidiary is hoping to change the dynamic through what they claim is a real-time claims management program leveraging tech. The post Is Optum Real For Real? appeared first on MedCity News.
In a placebo-controlled mid-stage study, Ventyx Biosciences’ oral NLRP3 inhibitor led to rapid and sustained reductions in levels of a protein that’s an indicator of cardiovascular disease risk. The brain-penetrating properties of this once-daily pill also have potential applications addressing inflammation that drives neurodegenerative disorders. The post Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Data is beginning to be liberated from static documents—and that represents a sea change